Advertisement

Index by author

May 01, 2002; Volume 30,Issue 5

  1. Fliter, Kristine L.

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

  2. Flockhart, David A.

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  3. Furuta, Shigeru

    1. Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

  4. Gaedigk, Andrea

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  5. Goodwin, Bryan J.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  6. Hendrickx, J.

    1. The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

  7. Hosokawa, Masakiyo

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  8. Hsieh, Faye

    1. Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

  9. Igarashi, Takashi

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

  10. Ishii, Itsuko

    1. Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 11) Next »
Back to top

In this issue

Advertisement